Table 2

PRC and AcSDKP concentrations from experiment 2

	PRC	AcSDKP
	PRC	Plasma	Urine	Kidney^2-a	Lung^2-a	Spleen^2-a	Bone Marrow
	ng Ang I/ml/h	pmol/ml		pmol/g tissue		pmol/g tissue	pmol/mg protein
Control	3.6 ± 0.4	1.12 ± 0.29	28 ± 24	289 ± 95	309 ± 84	2578 ± 647	3.75 ± 0.78
Captopril (3 mg/kg)	4.4 ± 1.1	1.98 ± 0.58^2-b	91 ± 58^2-b	393 ± 107	443 ± 156	2885 ± 1056	3.44 ± 1.38
Captopril (10 mg/kg)	11.5 ± 9.5^2-b ^c	3.05 ± 0.63^2-b ^c	90 ± 49^2-b	539 ± 163^2-b	426 ± 62	2773 ± 851	3.41 ± 1.65
Captopril (30 mg/kg)	50 ± 62^2-b ^c ^d	3.51 ± 0.87^2-b ^c	96 ± 53^2-b	386 ± 216	440 ± 106	2733 ± 708	3.69 ± 2.06
F _3,36	26^e	36^e	12^e	4.1^f	3.7^f	1.2	0.8

Data are means ± S.D.; n = 10 rats/group.F_3,36.

↵2-a Values corrected for blood contamination (seeExperimental Procedures).
↵2-b p < .05 versus control,^c p < .05 versus captopril (3 mg/kg),^d p < .05 versus captopril (10 mg/kg) by Scheffe test, ^e p < .001.,^f p < .05.